Improving Access and Multiple Sclerosis Care in Latin America
This webcast is a recording of a previously offered live, two-hour moderator-led panel of expert faculty representing various countries in Latin America who discussed the epidemiology of multiple sclerosis (MS) in the region, its health and socio-economic impact, diagnosis, assessment, treatment, biosimilar drugs, and evidenced-based solutions to managing MS in special populations.
This activity has been designed to meet the educational needs of multiple sclerosis specialists, neurologists, neurology Residents & Fellows, pharmacists and other medical professionals who actively treat patients with multiple sclerosis.
Discuss environmental factors contributing to the mechanism of disease, particularly pertaining to Latin America
- Address the differential diagnosis of MS with other emerging disorders in the Americas such as neuromyelitis optica and Anti-MOG associated encephalomyelitis
- Outline procedures to accomplish diagnostic criteria and avoid misdiagnosis of MS in Latin America
- Outline current and emerging therapies for the treatment of MS
- Assess the latest advances regarding the treatment and assessment of RRMS and progressive MS
- Review the differences between biosimilars and reference drugs and their appropriate use to ensure safety and efficacy for the treatment of MS
- Apply the latest data to devise appropriate treatment plans for special populations with MS including pregnancy
Activity Launch Date - 07/15/2020
Expiration Date - 07/15/2021
Brought to you by:
Disclosure of Commercial Support
This activity is supported by an educational grant provided by Biogen.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Statement of Independence
Horizon CME educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Horizon CME to develop and present educational activities that are timely, fair balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome comments about how to better serve your needs.
Copyright © 2020 - All rights reserved. This CME-certified program is held as copyrighted by Horizon CME. Through this notice, Horizon CME grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owners.